Tanvex BioPharma, Inc. (TPE:6541)
Taiwan
· Delayed Price · Currency is TWD 56.50
-0.30 (-0.53%)
At close: Dec 5, 2025
-21.85% (1Y)
| Market Cap | 14.96B |
| Revenue (ttm) | 224.83M |
| Net Income (ttm) | -1.36B |
| Shares Out | 264.82M |
| EPS (ttm) | -6.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 353,855 |
| Average Volume | 502,607 |
| Open | 57.00 |
| Previous Close | 56.80 |
| Day's Range | 55.70 - 57.50 |
| 52-Week Range | 48.10 - 82.00 |
| Beta | -0.06 |
| RSI | 56.91 |
| Earnings Date | Nov 7, 2025 |